Genmab — Maj 2017

[JohnW]

@EL, since revenue is another word for sales (at least in this context), how do you find 50% being different from 20%?

[JohnW]

hmm, I was trying to write to E L. I'm not sure why it shows up like that.

[JohnW]

50% not being different from 20%?

[bibob]

JKY. Kan ikke sende noget.

[JKY_VH]

mystisk, har du en mailadresse?

[bibob]

Yes. Du sendte en artikel til mig i jan - feb md fra jyske vestkysten. Har du ikke stadig min mail adresse. ?

[E_L]

Oh sorry for confusion, my mistake, profit offcourse instead of revenu

[E_L]

currently they take 20% on sales

[E_L]

they are looking for 50% on profits (share 50% of the rights)

[E_L]

I see the EL stock is down -1%
immediately Johnw

[JKY_VH]

5 min bibob:-

[JKY_VH]

[JohnW]

Ok, EL, now I understand.

[Bulder]

Tak for slides til Winkel-foredraget, Sukker. Nød især slide 37 og 43

[bibob]

Tak JKY. Har modtaget den fine artikel. Plessner er en guttermand.

[bibob]

Astellas har skippet et fase lll i NSCLC http://medwatch.dk/Medicinal___Biotek/article9577926.ece?utm_campaign=Middag&utm_content=2017-05-15 12%3A14%3A55&utm_medium=top&utm_source=Feed

[bibob]

Luk 1383

[Helge_LarsenPI-redaktør]

Dagens højeste.

[bibob]

Bulls eye.

[forsent]

E L: Ahh, thx for explaining :). Didn't know that actually, quite important